Hospital
Lehigh Valley Hospital
Lehigh Valley Hospital was paid $64.40M by Medicaid between Jan 2018 and Dec 2024, across 538 billing codes. Its largest line is 99284, emergency room visit (serious) — 30% of everything it billed.
33Billing provider infoLEHIGH VALLEY HOSPITAL
ALLENTOWN, PA 18103
ALLENTOWN, PA 18103
33aNPI1164400131assigned 01/09/2006
33bProvider typePsychiatric Hospital Unit
28Total paid$64.40M
24GClaims1,163,602
24DCodes billed538
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Psychiatric Hospital Unit providers in Pennsylvania
Rank by total paid#1 of 15
Median peer was paid$165K
This provider vs. median390×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official THOMAS, ROBERT controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,567 | $792K | |
| 2019 | 17,401 | $894K | |
| 2020 | 126,820 | $6.14M | |
| 2021 | 451,536 | $24.35M | |
| 2022 | 167,303 | $10.40M | |
| 2023 | 216,677 | $12.01M | |
| 2024incomplete | 176,298 | $9.82M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 30% | 88,362 | 85,681 | $19.31M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 63,777 | 61,651 | $11.83M |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 11% | 137,815 | 74,615 | $6.79M |
| G0378 | Hospital observation service, per hour | 7.3% | 4,100 | 3,271 | $4.70M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.2% | 24,613 | 23,770 | $4.66M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.2% | 13,253 | 12,756 | $770K |
| J9271 | Injection, pembrolizumab, 1 mg | 1.1% | 586 | 462 | $735K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 4,362 | 4,223 | $563K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 10,079 | 9,773 | $481K |
| 80053 | Comprehensive metabolic panel | <1% | 67,037 | 63,002 | $451K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 4,525 | 4,428 | $446K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 1,406 | 1,385 | $378K |
526 more codes
| X0621 | <1% | 1,433 | $353K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 3,258 | $351K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 3,351 | $316K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | <1% | 527 | $287K |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | <1% | 130 | $284K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 778 | $273K |
| 95782 | <1% | 303 | $267K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 258 | $264K |
| 97161 | <1% | 3,478 | $236K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 4,724 | $229K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 4,180 | $228K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 64,635 | $215K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 31,847 | $211K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 696 | $194K |
| 80061 | Lipid panel | <1% | 12,430 | $188K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 5,759 | $178K |
| 87536 | <1% | 1,619 | $177K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 572 | $173K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 10,270 | $170K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 868 | $168K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,215 | $163K |
| 72141 | <1% | 540 | $149K | |
| 74183 | <1% | 343 | $149K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 3,974 | $144K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 3,542 | $140K |
| 97162 | <1% | 2,218 | $136K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,489 | $135K |
| 72197 | <1% | 282 | $133K | |
| 450 | Pov group 1 hd 301-450 lbs | <1% | 144 | $133K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,910 | $132K |
| 73221 | <1% | 421 | $120K | |
| J2323 | Injection, natalizumab, 1 mg | <1% | 148 | $118K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,861 | $116K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 4,465 | $115K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,997 | $112K |
| 80050 | General health panel | <1% | 3,163 | $108K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 583 | $107K |
| 95806 | <1% | 1,207 | $106K | |
| 76770 | <1% | 1,655 | $103K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 2,428 | $102K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,767 | $101K |
| 76536 | <1% | 1,734 | $99K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,751 | $98K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 795 | $95K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 1,380 | $90K |
| 76642 | <1% | 1,774 | $89K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 11,008 | $81K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,524 | $79K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 2,667 | $78K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 484 | $76K |
| 77066 | Tomosynthesis, mammo | <1% | 751 | $76K |
| 74178 | <1% | 313 | $73K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,332 | $71K |
| 64615 | <1% | 502 | $69K | |
| 87631 | <1% | 1,079 | $69K | |
| 95700 | <1% | 306 | $64K | |
| 77065 | Tomosynthesis, mammo | <1% | 762 | $63K |
| 77386 | <1% | 231 | $63K | |
| 93971 | <1% | 1,088 | $62K | |
| 76830 | Ultrasound, transvaginal | <1% | 1,509 | $60K |
| 71250 | <1% | 847 | $59K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,861 | $58K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,644 | $58K |
| 62323 | <1% | 442 | $57K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 8,151 | $57K |
| 72158 | <1% | 221 | $57K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 950 | $54K |
| 84703 | <1% | 9,938 | $52K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 827 | $51K |
| 93975 | <1% | 696 | $50K | |
| J1750 | Injection, iron dextran, 50 mg | <1% | 2,797 | $48K |
| 97165 | <1% | 732 | $46K | |
| 93296 | <1% | 3,293 | $46K | |
| 86803 | <1% | 2,156 | $45K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 443 | $45K |
| 84484 | <1% | 10,412 | $45K | |
| 80081 | <1% | 494 | $45K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 570 | $44K |
| J0897 | Injection, denosumab, 1 mg | <1% | 86 | $43K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,780 | $43K |
| D1110 | Prophylaxis - adult | <1% | 1,273 | $43K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 697 | $42K |
| J0185 | Injection, aprepitant, 1 mg | <1% | 873 | $42K |
| 76813 | <1% | 644 | $42K | |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 610 | $41K |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 1,137 | $40K |
| 81003 | <1% | 22,742 | $40K | |
| 93970 | <1% | 426 | $39K | |
| 93226 | <1% | 894 | $38K | |
| 93017 | <1% | 897 | $36K | |
| 93976 | <1% | 461 | $36K | |
| 96417 | <1% | 561 | $35K | |
| 95708 | <1% | 267 | $35K | |
| 77080 | <1% | 584 | $35K | |
| 76775 | <1% | 742 | $35K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 937 | $34K |
| 16020 | <1% | 1,349 | $34K | |
| 72156 | <1% | 129 | $34K | |
| 97166 | <1% | 564 | $33K | |
| 97164 | <1% | 791 | $33K | |
| 96040 | <1% | 678 | $32K | |
| 74018 | <1% | 1,626 | $32K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 667 | $32K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 2,049 | $32K |
| 86480 | <1% | 420 | $31K | |
| 36430 | <1% | 187 | $30K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 507 | $30K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 758 | $30K |
| 86780 | <1% | 1,763 | $30K | |
| 73564 | <1% | 1,437 | $29K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,739 | $29K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,042 | $28K |
| 76885 | <1% | 256 | $28K | |
| 96415 | <1% | 747 | $28K | |
| 85027 | <1% | 3,743 | $27K | |
| 70544 | <1% | 124 | $27K | |
| 83690 | <1% | 8,131 | $27K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,421 | $27K |
| 64493 | <1% | 141 | $26K | |
| 92579 | <1% | 439 | $26K | |
| 76818 | <1% | 367 | $26K | |
| 77412 | <1% | 581 | $26K | |
| 77336 | <1% | 627 | $26K | |
| 72110 | <1% | 1,144 | $26K | |
| 84702 | <1% | 2,105 | $25K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,041 | $25K |
| 92587 | <1% | 722 | $25K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 362 | $25K |
| 94729 | <1% | 694 | $23K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 241 | $23K |
| 70486 | <1% | 349 | $23K | |
| 76821 | <1% | 353 | $23K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 3,976 | $23K |
| D0120 | Dental checkup, returning patient | <1% | 1,144 | $23K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,088 | $22K |
| 82728 | <1% | 1,807 | $22K | |
| 92523 | <1% | 259 | $22K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 34 | $22K |
| 96411 | <1% | 307 | $22K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,096 | $21K |
| 12001 | <1% | 180 | $21K | |
| 82570 | <1% | 3,082 | $21K | |
| 76870 | <1% | 456 | $20K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 566 | $19K |
| 97163 | <1% | 302 | $19K | |
| 78264 | <1% | 193 | $19K | |
| 93225 | <1% | 955 | $18K | |
| 95886 | <1% | 403 | $18K | |
| 82043 | <1% | 2,467 | $18K | |
| 93350 | <1% | 382 | $18K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 1,212 | $18K |
| 86360 | <1% | 275 | $18K | |
| 10005 | <1% | 131 | $18K | |
| 84466 | <1% | 1,003 | $18K | |
| 64483 | <1% | 98 | $17K | |
| 83970 | <1% | 390 | $16K | |
| 86003 | <1% | 95 | $16K | |
| 77334 | <1% | 228 | $16K | |
| 94726 | <1% | 490 | $16K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 2,635 | $16K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,762 | $16K |
| 80074 | <1% | 289 | $16K | |
| 73610 | <1% | 1,004 | $16K | |
| 97597 | <1% | 775 | $16K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 603 | $15K |
| 83880 | <1% | 1,187 | $15K | |
| 85610 | <1% | 5,315 | $15K | |
| 93923 | <1% | 274 | $15K | |
| 86706 | <1% | 1,022 | $15K | |
| 73030 | <1% | 1,037 | $15K | |
| 72050 | <1% | 515 | $14K | |
| 73630 | <1% | 1,391 | $14K | |
| 70491 | <1% | 211 | $14K | |
| 72082 | <1% | 282 | $14K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 475 | $14K |
| 86359 | <1% | 275 | $14K | |
| 77062 | <1% | 539 | $14K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 38 | $13K |
| 92567 | <1% | 890 | $13K | |
| 92557 | <1% | 377 | $13K | |
| 95954 | <1% | 411 | $13K | |
| 82784 | <1% | 562 | $12K | |
| 87522 | Neg quan hep c or qual rna | <1% | 304 | $12K |
| 73502 | <1% | 630 | $12K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 176 | $12K |
| 87800 | <1% | 623 | $11K | |
| 73130 | <1% | 1,054 | $11K | |
| 82947 | <1% | 6,425 | $11K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 697 | $11K |
| 82607 | <1% | 813 | $11K | |
| 86850 | <1% | 1,918 | $11K | |
| 93880 | <1% | 129 | $11K | |
| 71045 | Radiologic examination, chest; single view | <1% | 3,088 | $11K |
| 72146 | <1% | 56 | $11K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 31,855 | $11K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,049 | $11K |
| 83735 | <1% | 2,890 | $10K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 471 | $10K |
| 95819 | <1% | 416 | $10K | |
| 92611 | <1% | 266 | $10K | |
| 84403 | <1% | 338 | $10K | |
| 83540 | <1% | 1,131 | $10K | |
| 80076 | <1% | 1,014 | $10K | |
| 96401 | <1% | 307 | $10K | |
| 76820 | <1% | 327 | $10K | |
| 80305 | <1% | 1,795 | $9K | |
| 84439 | <1% | 1,138 | $9K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 39 | $9K |
| 49083 | <1% | 30 | $9K | |
| 96416 | <1% | 58 | $9K | |
| 73110 | <1% | 649 | $9K | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | <1% | 104 | $9K |
| 81001 | <1% | 4,997 | $9K | |
| 91200 | <1% | 305 | $8K | |
| 84480 | <1% | 939 | $8K | |
| 86038 | <1% | 532 | $8K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 22,234 | $8K |
| 86704 | <1% | 455 | $8K | |
| 84436 | <1% | 747 | $8K | |
| 87340 | <1% | 460 | $8K | |
| 96409 | <1% | 87 | $7K | |
| 83605 | <1% | 2,139 | $7K | |
| 17108 | <1% | 75 | $7K | |
| 86618 | <1% | 348 | $7K | |
| 72100 | <1% | 332 | $7K | |
| 74230 | <1% | 286 | $7K | |
| 88172 | <1% | 134 | $7K | |
| 84153 | <1% | 279 | $7K | |
| 70480 | <1% | 56 | $7K | |
| 78227 | <1% | 26 | $7K | |
| 74240 | <1% | 149 | $7K | |
| 10060 | <1% | 107 | $7K | |
| 84146 | <1% | 235 | $6K | |
| 86708 | <1% | 405 | $6K | |
| 96523 | <1% | 323 | $6K | |
| G0008 | Administration of influenza virus vaccine | <1% | 793 | $6K |
| 86900 | <1% | 1,996 | $6K | |
| 12011 | <1% | 66 | $6K | |
| 77387 | <1% | 92 | $6K | |
| D0274 | Bitewings - four radiographic images | <1% | 214 | $6K |
| 74221 | <1% | 103 | $6K | |
| 82105 | <1% | 272 | $6K | |
| 85379 | <1% | 1,316 | $6K | |
| J9395 | Injection, fulvestrant, 25 mg | <1% | 12 | $6K |
| 77300 | <1% | 150 | $6K | |
| 86901 | <1% | 1,980 | $6K | |
| 93798 | <1% | 209 | $5K | |
| 86235 | <1% | 283 | $5K | |
| 72131 | <1% | 89 | $5K | |
| 84460 | <1% | 587 | $5K | |
| 95910 | <1% | 75 | $5K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 19,874 | $5K |
| 90686 | <1% | 696 | $5K | |
| 70360 | <1% | 407 | $5K | |
| 85730 | <1% | 860 | $5K | |
| 59025 | Fetal non-stress test | <1% | 368 | $5K |
| 71271 | <1% | 52 | $5K | |
| 82746 | <1% | 367 | $5K | |
| 83655 | <1% | 391 | $5K | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 4,364 | $5K |
| 96376 | <1% | 742 | $5K | |
| 73590 | <1% | 359 | $5K | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 928 | $5K |
| J2704 | Injection, propofol, 10 mg | <1% | 10,553 | $4K |
| 73220 | <1% | 13 | $4K | |
| 84270 | <1% | 150 | $4K | |
| 82950 | <1% | 584 | $4K | |
| 86225 | <1% | 296 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 189 | $4K |
| 82962 | <1% | 2,677 | $4K | |
| 88185 | <1% | 14 | $4K | |
| 83001 | <1% | 224 | $4K | |
| 78306 | <1% | 82 | $4K | |
| 76882 | <1% | 505 | $4K | |
| 76827 | <1% | 82 | $4K | |
| 88173 | <1% | 137 | $4K | |
| 86200 | <1% | 275 | $4K | |
| 83021 | <1% | 175 | $4K | |
| 64400 | <1% | 30 | $4K | |
| 85652 | <1% | 1,466 | $4K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 13 | $4K |
| 74022 | <1% | 234 | $4K | |
| 76641 | <1% | 62 | $4K | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 512 | $4K |
| 94010 | <1% | 437 | $4K | |
| 86160 | <1% | 112 | $4K | |
| 80197 | <1% | 303 | $4K | |
| 72040 | <1% | 214 | $4K | |
| 72072 | <1% | 181 | $4K | |
| 90715 | <1% | 1,075 | $4K | |
| 81025 | <1% | 2,331 | $4K | |
| 86140 | <1% | 1,340 | $4K | |
| 96402 | <1% | 138 | $3K | |
| 72070 | <1% | 151 | $3K | |
| 73080 | <1% | 360 | $3K | |
| 73523 | <1% | 105 | $3K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 9,739 | $3K |
| 94727 | <1% | 161 | $3K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,282 | $3K |
| 94060 | <1% | 291 | $3K | |
| 87186 | <1% | 654 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 28,793 | $3K |
| 73560 | <1% | 223 | $3K | |
| D0140 | Limited oral evaluation - problem focused | <1% | 260 | $3K |
| 97168 | <1% | 70 | $3K | |
| 76825 | <1% | 123 | $3K | |
| 86431 | <1% | 372 | $3K | |
| 77049 | <1% | 12 | $3K | |
| 72157 | <1% | 12 | $3K | |
| 88313 | <1% | 58 | $3K | |
| 95885 | <1% | 73 | $3K | |
| 73140 | <1% | 367 | $3K | |
| 83525 | <1% | 217 | $3K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 2,201 | $3K |
| 87077 | <1% | 645 | $3K | |
| 62321 | <1% | 16 | $3K | |
| 82550 | <1% | 556 | $3K | |
| 84165 | <1% | 196 | $3K | |
| 80164 | <1% | 238 | $3K | |
| 84156 | <1% | 624 | $3K | |
| 71101 | <1% | 180 | $3K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,915 | $2K |
| 73552 | <1% | 163 | $2K | |
| 97167 | <1% | 41 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 9,520 | $2K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 80 | $2K |
| 77061 | <1% | 88 | $2K | |
| D0330 | Panoramic radiographic image | <1% | 70 | $2K |
| 83002 | <1% | 128 | $2K | |
| 74246 | <1% | 55 | $2K | |
| 92522 | <1% | 41 | $2K | |
| 84550 | <1% | 343 | $2K | |
| 70496 | <1% | 17 | $2K | |
| 77072 | <1% | 164 | $2K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 161 | $2K |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 94 | $2K |
| 73700 | <1% | 27 | $2K | |
| 84100 | <1% | 570 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 12,059 | $2K |
| D0210 | Intraoral - complete series of radiographic images | <1% | 46 | $2K |
| 84630 | <1% | 128 | $2K | |
| 87040 | <1% | 227 | $2K | |
| 92593 | <1% | 107 | $2K | |
| 92083 | <1% | 44 | $2K | |
| 88342 | <1% | 229 | $2K | |
| 95816 | <1% | 147 | $2K | |
| 74019 | <1% | 130 | $2K | |
| 85045 | <1% | 351 | $2K | |
| 73090 | <1% | 202 | $2K | |
| S0028 | Injection, famotidine, 20 mg | <1% | 3,527 | $2K |
| 83520 | <1% | 196 | $2K | |
| X0592 | <1% | 92 | $2K | |
| 82803 | <1% | 163 | $2K | |
| 87653 | <1% | 41 | $2K | |
| 84590 | <1% | 109 | $2K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 29 | $2K |
| A9270 | Non-covered item or service | <1% | 29,172 | $1K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 174 | $1K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 13 | $1K |
| 86039 | <1% | 95 | $1K | |
| 84425 | <1% | 177 | $1K | |
| 86255 | <1% | 43 | $1K | |
| 64405 | <1% | 13 | $1K | |
| 83615 | <1% | 213 | $1K | |
| 82670 | <1% | 54 | $1K | |
| 82533 | <1% | 95 | $1K | |
| 99153 | Mod sedat endo service >5yrs | <1% | 203 | $1K |
| 86800 | <1% | 64 | $1K | |
| 82330 | <1% | 324 | $1K | |
| 12002 | <1% | 14 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 259 | $1K |
| 64494 | <1% | 64 | $1K | |
| J9045 | Injection, carboplatin, 50 mg | <1% | 109 | $1K |
| 77280 | <1% | 31 | $1K | |
| 72220 | <1% | 62 | $1K | |
| D1206 | Topical application of fluoride varnish | <1% | 68 | $1K |
| 70498 | <1% | 13 | $999.12 | |
| 92133 | <1% | 85 | $981.34 | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 73 | $975.50 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 4,631 | $975.12 |
| J9190 | Injection, fluorouracil, 500 mg | <1% | 534 | $952.83 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 376 | $929.30 |
| 84132 | <1% | 340 | $926.84 | |
| 99152 | <1% | 235 | $918.24 | |
| 86617 | <1% | 48 | $889.76 | |
| J0640 | Injection, leucovorin calcium, per 50 mg | <1% | 341 | $888.67 |
| 83516 | <1% | 71 | $887.06 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,319 | $873.76 |
| 73562 | <1% | 48 | $858.43 | |
| 86695 | <1% | 40 | $858.30 | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 13 | $836.20 |
| 76506 | <1% | 13 | $827.97 | |
| 73660 | <1% | 117 | $815.49 | |
| 82977 | <1% | 78 | $780.48 | |
| 94761 | <1% | 164 | $775.98 | |
| 73060 | <1% | 99 | $746.08 | |
| 82248 | <1% | 96 | $723.36 | |
| 86696 | <1% | 28 | $714.93 | |
| 27096 | <1% | 12 | $695.82 | |
| 29125 | <1% | 61 | $682.99 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 7,987 | $677.41 |
| 94375 | <1% | 34 | $666.31 | |
| 80177 | <1% | 63 | $656.10 | |
| 86376 | <1% | 76 | $647.69 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 2,058 | $646.45 |
| 83498 | <1% | 27 | $631.94 | |
| 82785 | <1% | 30 | $600.68 | |
| 82627 | <1% | 24 | $593.48 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 3,987 | $578.81 |
| 86592 | <1% | 132 | $572.18 | |
| 96368 | <1% | 50 | $554.55 | |
| 86923 | <1% | 32 | $553.58 | |
| 76604 | <1% | 26 | $541.58 | |
| J2800 | Injection, methocarbamol, up to 10 ml | <1% | 1,599 | $530.71 |
| Q3014 | Telehealth originating site facility fee | <1% | 185 | $526.74 |
| 82805 | <1% | 41 | $511.43 | |
| 51798 | <1% | 161 | $488.06 | |
| 82810 | <1% | 113 | $478.41 | |
| 96367 | <1% | 59 | $466.51 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 677 | $451.78 |
| G0009 | Administration of pneumococcal vaccine | <1% | 44 | $426.71 |
| 85007 | <1% | 96 | $418.89 | |
| 87517 | <1% | 13 | $416.74 | |
| 76942 | <1% | 12 | $415.57 | |
| 97010 | <1% | 17 | $412.76 | |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 1,529 | $408.55 |
| 88184 | <1% | 14 | $403.89 | |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | <1% | 14 | $373.40 |
| 93308 | <1% | 29 | $362.15 | |
| 90732 | <1% | 12 | $360.63 | |
| 86665 | <1% | 16 | $344.75 | |
| 86762 | <1% | 14 | $334.11 | |
| 80178 | <1% | 75 | $333.81 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 394 | $329.76 |
| 93922 | <1% | 13 | $323.46 | |
| 87070 | <1% | 147 | $316.12 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 1,066 | $312.03 |
| 84481 | <1% | 13 | $302.67 | |
| 84295 | <1% | 224 | $294.10 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 786 | $288.58 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 3,970 | $283.25 |
| 82435 | <1% | 151 | $273.73 | |
| 82150 | <1% | 63 | $269.26 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 678 | $258.73 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 4,350 | $258.17 |
| 85018 | <1% | 142 | $243.66 | |
| J3411 | Injection, thiamine hcl, 100 mg | <1% | 640 | $238.36 |
| 86664 | <1% | 14 | $236.88 | |
| 82378 | <1% | 13 | $232.33 | |
| 86308 | <1% | 46 | $222.69 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 2,922 | $219.02 |
| C1769 | Guide wire | <1% | 109 | $215.55 |
| 73120 | <1% | 17 | $207.87 | |
| 72202 | <1% | 12 | $207.82 | |
| 86663 | <1% | 14 | $203.16 | |
| 87205 | <1% | 144 | $200.39 | |
| 82951 | <1% | 14 | $199.19 | |
| 86705 | <1% | 13 | $193.21 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,909 | $166.87 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 705 | $161.19 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 2,383 | $157.43 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 2,597 | $152.72 |
| 85014 | <1% | 105 | $151.85 | |
| J1815 | Injection, insulin, per 5 units | <1% | 2,201 | $150.42 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 474 | $147.70 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 4,545 | $137.85 |
| 87088 | <1% | 25 | $133.78 | |
| 99201 | <1% | 19 | $123.72 | |
| 92592 | <1% | 12 | $112.85 | |
| 64450 | <1% | 15 | $86.91 | |
| 91320 | <1% | 82 | $84.76 | |
| 82565 | <1% | 12 | $77.31 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 2,715 | $73.78 |
| 82140 | <1% | 14 | $65.93 | |
| 82010 | <1% | 36 | $64.47 | |
| 82375 | <1% | 24 | $57.94 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 277 | $54.60 |
| 84155 | <1% | 12 | $52.06 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 676 | $51.06 |
| 87147 | <1% | 12 | $48.00 | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | <1% | 654 | $39.99 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 1,104 | $39.23 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 1,480 | $33.01 |
| 88307 | <1% | 39 | $31.63 | |
| J3360 | Injection, diazepam, up to 5 mg | <1% | 170 | $31.58 |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 679 | $31.20 |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 250 | $28.63 |
| 88304 | <1% | 31 | $24.87 | |
| 87075 | <1% | 13 | $21.50 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 26 | $15.19 |
| 82009 | <1% | 17 | $10.54 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 203 | $6.46 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 0% | 499 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 474 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 0% | 427 | $0.00 |
| J1453 | Injection, fosaprepitant, 1 mg | 0% | 117 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 734 | $0.00 |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 0% | 63 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 101 | $0.00 |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | 0% | 251 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 842 | $0.00 |
| J3489 | Injection, zoledronic acid, 1 mg | 0% | 13 | $0.00 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 0% | 54 | $0.00 |
| S0030 | Injection, metronidazole, 500 mg | 0% | 28 | $0.00 |
| J0701 | Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg | 0% | 30 | $0.00 |
| J1953 | Injection, levetiracetam, 10 mg | 0% | 17 | $0.00 |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | 0% | 88 | $0.00 |
| 90687 | 0% | 15 | $0.00 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 19 | $0.00 |
| J3032 | Injection, eptinezumab-jjmr, 1 mg | 0% | 13 | $0.00 |
| 90375 | 0% | 12 | $0.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 0% | 101 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 41 | $0.00 |
| 90480 | 0% | 86 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 1,058 | $0.00 |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 0% | 218 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 0% | 121 | $0.00 |
| 88341 | 0% | 12 | $0.00 | |
| 90656 | 0% | 51 | $0.00 | |
| J1836 | Injection, metronidazole, 10 mg | 0% | 70 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 125 | $0.00 |
| V2788 | Presbyopia correcting function of intraocular lens | 0% | 29 | $0.00 |
| J3490 | Unclassified drugs | 0% | 15 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 30 | $0.00 |
| J2560 | Injection, phenobarbital sodium, up to 120 mg | 0% | 13 | $0.00 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTHOMAS, ROBERT (CHIEF ACCOUNTING OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Millennium Health, LLC | San Diego, CA | $579.29M |
| Lehigh Valley Hospital Pocono | East Stroudsburg, PA | $11.90M |
| Lehigh Valley Hospital Hazleton | Hazleton, PA | $11.69M |
| Lehigh Valley Hospital | Allentown, PA | $10.00M |
| Lehigh Valley Hospital - Schuylkill | Pottsville, PA | $6.83M |
| Lehigh Valley Hospital- Pocono | Dickson City, PA | $3.75M |
| Lehigh Valley Hospital | Allentown, PA | $2.90M |
| Lehigh Valley Hospital | Allentown, PA | $1.95M |
| Lehigh Valley Hospital, INC | Allentown, PA | $1.85M |
| Lehigh Valley Hospital | Allentown, PA | $1.40M |
| Lehigh Valley Hospital - Schuylkill | Saint Clair, PA | $744K |
| Maryland Wound & Amputation Prevention, LLC | Lutherville, MD | $399K |
| Robert L Thomas MD FCCP LLC | Walterboro, SC | $253K |
| A-One Home Health Services, LLC | Everett, WA | $236K |
| Avamere Home Health Care, LLC | Bellingham, WA | $234K |
| Lehigh Valley Hospital Schuylkill | Pottsville, PA | $218K |
| Lehigh Valley Hospital Hazleton | Hazleton, PA | $193K |
| Prime Home Health, LLC | Federal Way, WA | $115K |
| Lehigh Valley Hospital | Allentown, PA | $70K |
| Northwest Hospice LLC | Tigard, OR | $33K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.